Relmada Therapeutics
RLMD
RLMD
69 hedge funds and large institutions have $40.2M invested in Relmada Therapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
58% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 26
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Holders
69
Holding in Top 10
–
Calls
$1.67M
Puts
$520K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$970K | |
| 3 | +$569K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$255K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$220K |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$1.81M | |
| 3 | -$606K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$389K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$344K |